Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Statement regarding Marston's PLC

11 Feb 2021 07:00

RNS Number : 6911O
Platinum Equity Advisors Int (UK)
11 February 2021
 

FOR IMMEDIATE RELEASE

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

11 February 2021

Platinum Equity Advisors, LLC ("Platinum")

Statement regarding Marston's PLC ("Marston's")

Platinum notes Marston's statement addressing press speculation on 29 January 2021 regarding a possible cash offer for the entire issued, and to be issued, share capital of Marston's (the "Proposal") and Marston's subsequent rejection of the Proposal on 1 February 2021. Platinum today announces that, after careful consideration, it does not intend to submit a revised proposal and it will not make a firm offer for Marston's.

Accordingly, this is a statement to which Rule 2.8 of the Code applies.

Under Note 2 on Rule 2.8 of the Code, Platinum reserves the right to set the restrictions in Rule 2.8 aside in the following circumstances:

(a) with the agreement of the board of Marston's;

(b) if a third party announces a firm intention to make an offer for Marston's;

(c) if Marston's announces a "whitewash" proposal (see Note 1 of the Notes on Dispensations from Rule 9) or a reverse takeover (as defined in the Code); or

(d) if there has been a material change of circumstances (as determined by the Takeover Panel).

 

Enquiries:

 

Platinum +1 310 282 9202

Dan Whelan

 

 

Important notices

 

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction, whether pursuant to this announcement or otherwise.

 

The release, distribution or publication of this announcement in jurisdictions outside the United Kingdom may be restricted by laws of the relevant jurisdictions and therefore persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

 

The information contained within this announcement is considered by Platinum to constitute inside information as stipulated under the Market Abuse Regulations (EU) No.596/2014 (as amended in the United Kingdom from 1 January 2021). Upon the publication of this announcement via a Regulatory Information Service, this inside information will be considered to be in the public domain.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OFDSFIFUSEFSEIE
Date   Source Headline
1st Jun 20262:38 pmRNSTotal Voting Rights
19th May 202611:12 amRNSDirector Declaration
12th May 20267:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 28 MARCH 2026
1st Apr 20263:12 pmRNSTotal Voting Rights
2nd Mar 202611:43 amRNSTotal Voting Rights
23rd Feb 20265:33 pmRNSHolding(s) in Company
11th Feb 202611:21 amRNSDirector/PDMR Shareholding
2nd Feb 20263:28 pmRNSTotal Voting Rights
28th Jan 202612:37 pmRNSResult of AGM
28th Jan 20267:00 amRNSTrading update for the 17 weeks to 24 January 2026
12th Jan 20262:00 pmRNSBlock listing Interim Review
9th Jan 20269:30 amRNSPurchase of shares into the EBT
2nd Jan 20262:55 pmRNSTotal Voting Rights
29th Dec 202510:46 amRNSDirector/PDMR Shareholding
29th Dec 202510:46 amRNSDirector/PDMR Shareholding
29th Dec 202510:44 amRNSDirector/PDMR Shareholding
29th Dec 202510:44 amRNSDirector/PDMR Shareholding
12th Dec 202511:07 amRNSAnnual Financial Report
11th Dec 20259:54 amRNSPurchase of shares into the EBT
1st Dec 20254:15 pmRNSTotal Voting Rights
28th Nov 202512:36 pmRNSDirector/PDMR Shareholding
28th Nov 202512:30 pmRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSPRELIMINARY RESULTS
28th Oct 20254:54 pmRNSHolding(s) in Company
8th Oct 20257:00 amRNSTrading Update for 52 weeks to 27 September 2025
1st Oct 20254:16 pmRNSTotal Voting Rights
1st Sep 20253:22 pmRNSTotal Voting Rights
1st Aug 20254:17 pmRNSTotal Voting Rights
22nd Jul 20257:00 amRNSTrading Update for the 41 weeks to 12 July 2025
9th Jul 20252:35 pmRNSBlock listing Interim Review
1st Jul 20255:03 pmRNSTotal Voting Rights
26th Jun 20257:05 amRNSAppointment of Chief Financial Officer
13th May 20257:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 29 MARCH 2025
1st May 20253:04 pmRNSTotal Voting Rights
1st Apr 20251:40 pmRNSTotal Voting Rights
20th Mar 202512:48 pmRNSPurchase of shares into the EBT
17th Mar 20251:10 pmRNSPurchase of shares into the EBT
4th Mar 20257:00 amRNSDirectorate Change
25th Feb 20259:24 amRNSHolding(s) in Company
21st Jan 20253:21 pmRNSResult of AGM
21st Jan 20257:00 amRNSTrading Update for the 16 weeks to 18 January 2025
13th Jan 20253:36 pmRNSPurchase of shares into the EBT
10th Jan 202510:13 amRNSBlock listing Interim Review
8th Jan 202511:55 amRNSHolding(s) in Company
2nd Jan 202511:27 amRNSTotal Voting Rights
23rd Dec 202412:15 pmRNSDirector/PDMR Shareholding
20th Dec 202410:47 amRNSPurchase of shares into the EBT
17th Dec 20244:22 pmRNSAnnual Financial Report
12th Dec 20242:59 pmRNSDirector/PDMR Shareholding
6th Dec 20249:51 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.